Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT05247632
Active, not recruiting Observational

Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study

NCT05247632 · tracked via the Priya Life Science China tracker
Sponsor
Zhejiang University
Phase
Observational
Started
2018-05-01
Last updated
2024-01-10

Condition(s) studied

Chronic Diseases

Study summary

The associations between food nutrition and safety factors with the risk of chronic diseases are still unclear. This study is conducted in Jinhua, a city with a high prevalence of chronic diseases in China, to assess relations between food nutrition and safety factors and chronic diseases.

Eligibility

Sex
ALL
Min age
45 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Subject aged ≥45 and ≤74 years old * Subject has complete data on diet and follow-up time Exclusion Criteria: had the major illness that had made personal life disabled

Primary outcome measure(s)

  • Numbers of participants with metabolic syndrome — From entry into the study baseline:2018 until 2023
    metabolic syndrome
  • Numbers of participants with obesity — From entry into the study baseline:2018 until 2023
    Obesity
  • Numbers of participants with diabetes — From entry into the study baseline:2018 until 2023
    Diabetes

Trial sites (2)

FacilityCityRegionStatus
Lanxi Red Cross Hospital Lanxi Zhejiang
Lanxi Hospital of Traditional Chinese Medicine Jinhua China

More Zhejiang University trials in China

Video Double-Lumen Tube for Secondary Pulmonary Resection Starting soon
Blinatumomab Combined With Venetoclax as Maintenance Therapy After Allo-HSCT in High-risk Ph Negative Acute B-cell Lymphoblastic Leukemia Active, not recruiting
Lifestyle and Dietary Pattern in Relation to Precursor Lesions of Colorectal Cancer and Cardiometabolic Diseases Active, not recruiting
Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC) Recruiting
Feasibility and Safety of Supraglottic Oxygen Delivery Via an Endotracheal Tube for Non-intubated ERCP Anesthesia: A Two-Stage Phase II Clinical Study Recruiting

Other trials for the same condition

Real-World Data Linkage Research Platform Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05247632 on ClinicalTrials.gov ↗ ← All trials in China